The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Neutrophil-mediated innate immune resistance to mycobacteria
Open accessAbstract
Neutrophils contain antimicrobial peptides with antituberculous activity, but their contribution to immune resistance to tuberculosis (TB) infection has not been previously investigated to our knowledge. We determined differential white cell counts in peripheral blood of 189 adults who had come into contact with patients diagnosed with active TB in London, United Kingdom, and evaluated them for evidence of TB infection and capacity to restrict mycobacterial growth in whole-blood assays. Risk of TB infection was inversely and independently associated with peripheral blood neutrophil count in contacts of patients diagnosed with pulmonary TB. The ability of whole blood to restrict growth of Mycobacterium bovis bacille Calmette Guérin and Mycobacterium tuberculosis was impaired 7.3- and 3.1-fold, respectively, by neutrophil depletion. In microbiological media, human neutrophil peptides (HNPs) 1-3 killed M. tuberculosis. The neutrophil peptides cathelicidin LL-37 and lipocalin 2 restricted growth of the organism, the latter in an iron-dependent manner. Black African participants had lower neutrophil counts and lower circulating concentrations of HNP1-3 and lipocalin 2 than south Asian and white participants. Neutrophils contribute substantially to innate resistance to TB infection, an activity associated with their antimicrobial peptides. Elucidation of the regulation of neutrophil antimicrobial peptides could facilitate prevention and treatment of TB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, Lcn2−/− mice are more susceptible to mycobacterial infections (214), which might be different from the iron-sequestrating role of Lcn2 (215) but rather due to its function as efficient chemoattractant for neutrophils to sites of infection (216–218).”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [215]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression
Wang, T. T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J. L., Tavera-Mendoza, L. E., Lin, R., Hanrahan, J. W., Mader, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.2909 · Cited by 1,661
Goetz, D. H., Holmes, M. A., Borregaard, N., Bluhm, M. E., Raymond, K. N., & Strong, R. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00708-6 · Cited by 1,355
Global epidemiology of tuberculosis
Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68384-0 · Cited by 717
Rodríguez, G. M., Voskuil, M. I., Gold, B., Schoolnik, G. K., & Smith, I. (2002) · Infection and Immunity · doi:10.1128/iai.70.7.3371-3381.2002 · Cited by 493
Martineau, A. R., Wilkinson, K. A., Newton, S. M., Floto, R. A., Norman, A. W., Skolimowska, K., Davidson, R. N., Sørensen, O. E., Kampmann, B., Griffiths, C. J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7190 · Cited by 410
Self-citationRacial Differences in Susceptibility to Infection byMycobacterium tuberculosis
Stead, W. W., Senner, J. W., Reddick, W. T., & Lofgren, J. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220702 · Cited by 406
Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000
Joint Tuberculosis Committee of the British Thoracic Society (2000) · Thorax · doi:10.1136/thorax.55.11.887 · Cited by 367
Iron, mycobacteria and tuberculosis
Ratledge, C. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.08.012 · Cited by 344
Flagged first, then by citations
Research works printed but not linked: 2
- Fu, 2003, Int. J. Tuberc. Lung Dis., 7, 1027
- Garrey, 1935, Phys. Rev., 15, 597
Cited by
Sorted by citations
Items 201–300 of 394
Roles of phosphatidyl inositol 3 kinase gamma (PI3Kγ) in respiratory diseases
Sala, V., Sala, A. D., Ghigo, A., & Hirsch, E. (2021) · Cell Stress · doi:10.15698/cst2021.04.246 · Cited by 23
Guinea pig neutrophil–macrophage interactions during infection with Mycobacterium tuberculosis
Sawant, K. V., Cho, H., Lyons, M. J., Ly, L. H., & McMurray, D. N. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.05.009 · Cited by 22
Allen, A. C., Malaga, W., Gaudin, C., Volle, A., Moreau, F., Hassan, A., Astarie‐Dequeker, C., Peixoto, A., Antoine, R., Pawlik, A., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00938-4 · Cited by 22
Kaneider, N. C., Djanani, A. M., & Wiedermann, C. J. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.285 · Cited by 21
Immuno-Stimulatory Peptides as a Potential Adjunct Therapy against Intra-Macrophagic Pathogens
Silva, T., & Gomes, M. S. (2017) · Molecules · doi:10.3390/molecules22081297 · Cited by 21
Leisching, G. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01669 · Cited by 21
Feng, H., Yan, L., Zhao, Y., Li, Z., & Kang, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.787681 · Cited by 20
Striking the Right Balance Determines TB or Not TB
Dasgupta, S. B., & Pieters, J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00455 · Cited by 21
A novel assay of antimycobacterial activity and phagocytosis by human neutrophils
Lowe, D. M., Bangani, N., Mehta, M. R., Lang, D. M., Rossi, A. G., Wilkinson, K. A., Wilkinson, R. J., & Martineau, A. R. (2013) · Tuberculosis · doi:10.1016/j.tube.2012.11.014 · Cited by 19
Self-citationSantos, A. P., Rodrigues, L. S., Rother, N., Mello, F. C. D. Q., & Magis-Escurra, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1528074 · Cited by 21
Pomaznoy, M., Kuan, R., Lindvall, M., Burel, J. G., Seumois, G., Vijayanand, P., Taplitz, R., Gilman, R. H., Saito, M., Lewinsohn, D. M., et al. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000031 · Cited by 19
Lowe, D. M., Bangani, N., Goliath, R. T., Kampmann, B., Wilkinson, K. A., Wilkinson, R. J., & Martineau, A. R. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201507-463oc · Cited by 19
Self-citationThe roles of neutrophils in non-tuberculous mycobacterial pulmonary disease
Alkarni, M., Lipman, M. C. I., & Lowe, D. M. (2023) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-023-00562-6 · Cited by 19
Immunology ofMycobacterium tuberculosisInfections
Sia, J. K., & Rengarajan, J. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch64 · Cited by 22
Apoptosis and oxidative burst in neutrophils infected with Mycobacterium spp.
González‐Cortés, C., Reyes-Ruvalcaba, D., Diez‐Tascón, C., & Rivero-Lezcano, O. M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.07.006 · Cited by 18
Espinosa, E., Ormsby, C. E., Vega-Barrientos, R. S., Ruiz‐Cruz, M., Moreno‐Coutiño, G., Peña‐Jiménez, Á., Peralta-Prado, A., Cantoral-Díaz, M.-T., Romero‐Rodríguez, D. P., & Reyes‐Terán, G. (2010) · International Journal of STD & AIDS · doi:10.1258/ijsa.2010.010135 · Cited by 18
Kewcharoenwong, C., Rinchai, D., Nithichanon, A., Bancroft, G. J., Ato, M., & Lertmemongkolchai, G. (2016) · Scientific Reports · doi:10.1038/srep34794 · Cited by 17
Host-directed therapy against tuberculosis: Concept and recent developments
Udinia, S., Suar, M., & Kumar, D. (2023) · Journal of Biosciences · doi:10.1007/s12038-023-00374-y · Cited by 15
The secret trumps, impelling the pathogenicity of tubercle bacilli
Cardona, P.-J., & Iványi, J. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(11)70013-1 · Cited by 16
Blood Cells and Interferon-Gamma Levels Correlation in Latent Tuberculosis Infection
Takenami, I., Loureiro, C. M., Machado, A., Emodi, K., Riley, L. W., & Arruda, S. M. (2013) · ISRN Pulmonology · doi:10.1155/2013/256148 · Cited by 16
Baguma, R., Penn‐Nicholson, A., Smit, E., Erasmus, M., Day, J., Makhethe, L., de Kock, M., Hughes, E. J., van Rooyen, M., Pienaar, B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184563 · Cited by 16
Roque‐Borda, C. A., Vishwakarma, S. K., Delgado, O. J. R., Rodrigues, H. L. D. S., Primo, L. M. D. G., Campos, I. C., de Lima, T. S., Perdigão, J., & Pavan, F. R. (2025) · Pharmaceuticals · doi:10.3390/ph18101440 · Cited by 19
The uncharted territory of host-pathogen interaction in tuberculosis
Ghoshal, A., Verma, A., Bhaskar, A., & Dwivedi, V. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1339467 · Cited by 18
Vilaplana, C., & Cardona, P.-J. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00055 · Cited by 15
Baguma, R., Mbandi, S. K., Rodo, M., Erasmus, M., Day, J., Makhethe, L., de Kock, M., van Rooyen, M., Stone, L., Bilek, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639965 · Cited by 18
Mattila, J. T., Beaino, W., White, A. G., Nyiranshuti, L., Maiello, P. A., Tomko, J. A., Frye, L. J., Fillmore, D. J., Scanga, C. A., Lin, P. L., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00826 · Cited by 15
Inflammation and Immunopathogenesis of Tuberculosis Progression
Lyadova, I. V. (2012) · InTech eBooks · doi:10.5772/32060 · Cited by 15
Fer et prédisposition aux infections
de Pontual, L. (2017) · Archives de Pédiatrie · doi:10.1016/s0929-693x(17)24004-4 · Cited by 15
Hodgkinson, J. W., Ge, J. Q., Katzenback, B. A., Havixbeck, J. J., Barreda, D. R., Stafford, J. L., & Belosevic, M. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.07.016 · Cited by 14
Jayachandran, R., Scherr, N., & Pieters, J. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.95 · Cited by 14
Park, J. M., Lee, H., Kim, Y., kim, K., Lee, W., Lee, K. ‐., Park, Y.-J., Kahng, J., Kwon, H. J., Kim, Y., et al. (2013) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12148 · Cited by 13
Role of MHC class Ib molecule, H2-M3 in host immunity against tuberculosis
Mir, S. A., & Sharma, S. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.005 · Cited by 13
Gaikwad, A. N., & Sinha, S. K. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03585.x · Cited by 13
Human Polymorphisms as Clinical Predictors in Leprosy
de, E. P. M. (2011) · Journal of Tropical Medicine · doi:10.1155/2011/923943 · Cited by 13
Campos, G. N. L., Velarde‐Félix, J. S., Ramírez, L. S., Salazar, S., Corona-Nakamura, A. L., Tapia, G. A., & de, E. P. M. (2013) · International Journal of Immunogenetics · doi:10.1111/iji.12080 · Cited by 12
Zhao, J., Gao, S., Chen, C., Li, H., Wang, S., Yong-min, Y., & Ming, L. (2022) · PeerJ · doi:10.7717/peerj.12776 · Cited by 12
Eosinophil Polymorphonuclear Leukocytes in TB: What We Know so Far
Babu, S. P., Narasimhan, P. B., & Babu, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02639 · Cited by 12
Rajamanickam, A., Munisankar, S., Dolla, C. K., & Babu, S. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00165 · Cited by 12
Parker, H. A., Dickerhof, N., Forrester, L., Ryburn, H. W. K., Smyth, L. C. D., Messens, J., Aung, H. L., Cook, G. M., Kettle, A. J., & Hampton, M. B. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001084 · Cited by 12
Role of hematopoietic cells in Mycobacterium tuberculosis infection
Tamburini, B., Badami, G. D., Azgomi, M. S., Dieli, F., Manna, M. P. L., & Caccamo, N. (2021) · Tuberculosis · doi:10.1016/j.tube.2021.102109 · Cited by 14
Human Immunology of Tuberculosis
Scriba, T. J., Coussens, A. K., & Fletcher, H. A. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch11 · Cited by 13
Tuberculosis vaccination needs to avoid ‘decoy’ immune reactions
Iványi, J. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.102021 · Cited by 11
Marshall, J. L., Satti, I., Surakhy, M., Harris, S. A., Morrison, H., Wittenberg, R. E., Álvarez, M. P. P., Li, S., Ramon, R. L., Hoogkamer, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60285-4 · Cited by 15
Sudadech, P., Roytrakul, S., Kaewprasert, O., Sirichoat, A., Chetchotisakd, P., Kanthawong, S., & Faksri, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260003 · Cited by 11
The Synthetic Cathelicidin HHC-10 Inhibits Mycobacterium bovis BCG In Vitro and in C57BL/6 Mice
Llamas-González, Y. Y., Pedroza-Roldán, C., Cortés-Serna, M. B., Márquez-Aguirre, A. L., Gálvez-Gastélum, F. J., & Flores‐Valdez, M. A. (2012) · Microbial Drug Resistance · doi:10.1089/mdr.2012.0149 · Cited by 11
Hopewell, P. C., Kato‐Maeda, M., & Ernst, J. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00035-x · Cited by 11
Exploring the role of neutrophils in infectious and noninfectious pulmonary disorders
Arora, A., & Singh, A. (2023) · International Reviews of Immunology · doi:10.1080/08830185.2023.2222769 · Cited by 12
Wang, P.-H., Lin, S., Liou, H., Chen, C., Shu, C., Lee, C., Tsai, M., & Yu, C. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00839-5 · Cited by 12
Hazrati, A., Mirarefin, S. M. J., Malekpour, K., Rahimi, A., Khosrojerdi, A., Rasouli, A., Akrami, S., & Soudi, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1469696 · Cited by 10
How Mycobacterium tuberculosis Manipulates Innate and Adaptive Immunity – New Views of an Old Topic
Brighenti, S., & Lerm, M. (2012) · InTech eBooks · doi:10.5772/29651 · Cited by 11
Arteche-Villasol, N., Gutiérrez-Expósito, D., Criado, M., Benavides, J., & Pérez, V. P. (2022) · Vaccines · doi:10.3390/vaccines10091403 · Cited by 10
Impaired CXCR1-dependent oxidative defence in active tuberculosis patients
Alaridah, N., Winqvist, N., Håkansson, G., Tenland, E., Rönnholm, A., Sturegård, E., Björkman, P., & Godaly, G. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.07.008 · Cited by 10
Adam, L., López-González, M., Björk, A., Pålsson, S. A., Poux, C., Wahren‐Herlenius, M., Fernández, C., & Spetz, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01939 · Cited by 12
Survival strategies of Mycobacterium tuberculosis inside the human macrophage
Welin, A. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 10
Murphy, D. M., Walsh, A., Stein, L., Petrasca, A., Cox, D. J., Brown, K. E., Duffin, E., Jameson, G., Connolly, S. A., O’Connell, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052898 · Cited by 9
VapC12 ribonuclease toxin modulates host immune response during Mycobacterium tuberculosis infection
Tyagi, S., Sadhu, S., Sharma, T., Paul, A., Pandey, M., Nain, V. K., Rathore, D. K., Chatterjee, S., Awasthi, A., & Pandey, A. K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1302163 · Cited by 9
The Immune Response to Mycobacterium tuberculosis Infection in Humans
Theodor, Z. (2013) · InTech eBooks · doi:10.5772/54986 · Cited by 9
Roy, R. B., Sambou, B., Uhía, I., Roetynck, S., Robertson, B. D., & Kampmann, B. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00151 · Cited by 9
Self-citationLalvani, A., & Seshadri, C. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz261 · Cited by 9
Nhamoyebonde, S., Chambers, M., Ndlovu, L., Karim, F., Mazibuko, M., Mhlane, Z., Madziwa, L., Moosa, M. S., Moodley, S., Hoque, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1422836 · Cited by 7
Peruhype-Magalhães, V., de Araújo, F. F., Morais-Papini, T. F., Wendling, A. P. B., Campi‐Azevedo, A. C., Coelho-dos-Reis, J. G. A., de Almeida, I. N., Antonelli, L. R. D. V., do Amaral, L. R., Gomes, M. D. S., et al. (2022) · Cytokine · doi:10.1016/j.cyto.2022.156076 · Cited by 8
Correlates of Protection from Tuberculosis
Álvarez, M. P. P., Marshall, J. L., & Tanner, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-24355-4_6 · Cited by 10
Bok, J., Hofland, R. W., & Evans, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641082 · Cited by 8
Kroon, E. E., Correa-Macedo, W., Evans, R., Seeger, A., Engelbrecht, L., Kriel, J., Loos, B., Okugbeni, N., Orlova, M., Cassart, P., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010888 · Cited by 8
Self-citationHe, W., Castiblanco, J., Walter, E. A., Okulicz, J. F., & Ahuja, S. K. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833f2087 · Cited by 8
The Importance of Lung Innate Immunity During Health and Disease
Ryanto, G. R. T., Suraya, R., & Nagano, T. (2025) · Pathogens · doi:10.3390/pathogens14010091 · Cited by 7
A controversial role of neutrophils in tuberculosis infection pathogenesis
Linge, I. A., & Apt, A. S. (2021) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-acr-1670 · Cited by 7
Wu, D., Cheng, Y.-C., Wang, C., Hung, C., Chen, P., Hu, S. C., Lin, C. R., Chen, S., & Kuo, C. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113215 · Cited by 7
The Role of NK Cells in Bacterial Infections
McSharry, B. P., & Gardiner, C. M. (2009) · Springer eBooks · doi:10.1007/978-3-642-02309-5_7 · Cited by 7
Gr1int/high Cells Dominate the Early Phagocyte Response to Mycobacterial Lung Infection in Mice
Ryder, B. M., Sandford, S., Manners, K. M., Dalton, J. P., Wiles, S., & Kirman, J. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00402 · Cited by 7
Castañeda‐Delgado, J. E., Cervantes-Villagrana, A. R., Serrano, C. J., Frausto-Lujan, I., Rivas-Santiago, C., Enciso‐Moreno, J. A., & Rivas-Santiago, B. T. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276140348 · Cited by 7
Host Pathogen Biology for AirborneMycobacterium tuberculosis
Arnett, E., Krishnan, N., Robertson, B. D., & Schlesinger, L. S. (2016) · Wiley eBooks · doi:10.1002/9781118943182.ch2 · Cited by 7
Chowdhury, C. S., Kinsella, R. L., Nehls, E. M., Naik, S. K., Lane, D. S., Talukdar, P., Chavez, S. M., Smirnov, A., Beatty, W. L., Kreamalmeyer, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.29.518376 · Cited by 7
Pang, T., Wang, L., Zhang, J., & Duan, S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1615302 · Cited by 7
Bangani, N., Nakiwala, J. K., Martineau, A. R., Wilkinson, R. J., Wilkinson, K. A., & Lowe, D. M. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001103 · Cited by 6
Self-citationJuarez‐Ortega, M., Rojas-Espinosa, O., Muñiz‐Salazar, R., Becerril‐Villanueva, E., Hernández-Solís, A., Arce‐Paredes, P., Islas-Trujillo, S., & Cicero-Sabido, R. J. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s171289 · Cited by 6
Acen, E. L., Worodria, W. O., Kateete, D. P., Olum, R., Joloba, M. L., Akintola, A. A., Bbuye, M., & Andia, I. (2023) · Scientific Reports · doi:10.1038/s41598-023-32543-2 · Cited by 6
Circular RNAs in tuberculosis: From mechanism of action to potential diagnostic biomarker
Kazemi, S., Mirzaei, R., Karampoor, S., Hosseini‐Fard, S. R., Ahmadyousefi, Y., Soltanian, A. R., Keramat, F., Saidijam, M., & Alikhani, M. Y. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106459 · Cited by 7
Juan-García, J., García‐García, S., Guerra-Laso, J. M., Raposo‐García, S., Diez‐Tascón, C., Nebreda-Mayoral, T., López-Fidalgo, E., López-Medrano, R., Fernández-Maraña, A., & Rivero-Lezcano, O. M. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx109 · Cited by 6
Cross, G. B., Yeo, B. C. M., Hutchinson, P. E., Tan, M. C., Verma, R., Lu, Q., & Paton, N. I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216616 · Cited by 6
Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis
Kato, S., Inui, N., Hozumi, H., Inoue, Y., Yasui, H., Karayama, M., Kono, M., Suzuki, Y., Furuhashi, K., Enomoto, N., et al. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.01.004 · Cited by 6
Serum siderocalin levels in patients with tuberculosis and HIV infection
Varghese, G. M., Turaka, V. P., Janardhanan, J., Yadav, S., Lakshmi, K. M., S, V. T., & Cherayil, B. J. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.05.020 · Cited by 6
Viswanathan, G., Hughes, E. J., Gan, M., Xet-Mull, A. M., Lowy, J. P., Pyle, C. J., Alexander, G. C., Swain-Lenz, D., Liu, Q., & Tobin, D. M. (2026) · Science Advances · doi:10.1126/sciadv.adw4619 · Cited by 5
Vitamin D and Macrophage Functions in Tuberculosis
Selvaraj, P. (2015) · Macrophage · doi:10.14800/macrophage.756 · Cited by 5
Immuno-Modulatory Role for the Treatment and Management of Tuberculosis
Prabhu, Y. A., Sarathy, M. V., & Tingirikari, J. M. R. (2022) · Springer eBooks · doi:10.1007/978-981-16-6379-6_9 · Cited by 5
Fol, M., Głobińska, A., Stączek, P., Kowalewicz‐Kulbat, M., Druszczyńska, M., Madiraju, M. V. V. S., & Rudnicka, W. (2013) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.60.2013.2.4 · Cited by 5
Acute Myeloid Leukemia Presenting with Pulmonary Tuberculosis
Thomas, M. M., & Al-Gherbawe, M. (2014) · Case Reports in Infectious Diseases · doi:10.1155/2014/865909 · Cited by 5
Tuberculosis: laboratory diagnosis and treatment strategies
McHugh, T. D. (2013) · CABI eBooks · doi:10.1079/9781845938079.0000 · Cited by 5
Innate Cellular Immunity in Newly Diagnosed Pulmonary Tuberculosis Patients and During Chemotherapy
Edem, V. F., & Arinola, G. O. (2016) · Annals of Global Health · doi:10.1016/j.aogh.2015.08.012 · Cited by 5
Martineau, A. R., Jolliffe, D. A., & Demaret, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00103-6 · Cited by 5
Self-citationTorun, E., Çakır, E., Çetin, E. A., Gedik, A. H., & Deniz, G. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000109 · Cited by 5
Unveiling the potential of antimicrobial peptides to combat Mycobacterium tuberculosis
Gupta, S., Kaur, R., Upadhyay, A., Singh, J., Sharma, B. P., & Sohal, J. S. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04393-1 · Cited by 4
Jiang, L., Su, Z., Zhang, Y., Liu, H., & Wang, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-12232-y · Cited by 5
Human neutrophil peptide-1 decreases during ageing in selected Mexican population
Rivas-Santiago, B. T., Castañeda‐Delgado, J. E., de Haro‐Acosta, J., Torres-Juárez, F., Frausto-Lujan, I., Marín-Luevano, P., González‐Amaro, R., & Enciso‐Moreno, J. A. (2015) · Immunologic Research · doi:10.1007/s12026-015-8689-2 · Cited by 4
Flores‐Villalva, S., Rémot, A., Carreras, F., Winter, N., Gordon, S. V., & Meade, K. G. (2022) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2022.110536 · Cited by 4
Javan, M. R., nezhad, A. A. J., Shahraki, S., Safa, A., Aali, H., & Kiani, Z. (2016) · International journal of basic science in medicine · doi:10.15171/ijbsm.2016.10 · Cited by 4
Vitamin D in the treatment and prevention of tuberculosis
Martineau, A. R., Griffiths, C., & Wilkinson, R. J. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.2.105 · Cited by 4
Self-citationWu, B., Li, C., Du, Z., Zhou, F., Xie, J., LUO, L.-W., Wu, J., Zhang, P., Xu, L., & Li, E. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2465 · Cited by 4
Browning, S. E., Bharaj, P., Fan, X., Nguyen, H. P., Holloway, A. J., Naqvi, K. F., Lisinicchia, J. G., Paez, R. N., Chauhan, S., Huante, M. B., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1597281 · Cited by 3
The host immune response to Mycobacterium tuberculosis determining protection or disease progression
Saraiva, M., Branchett, W. J., Rengarajan, J., & O’Garra, A. (2026) · Nature Immunology · doi:10.1038/s41590-026-02529-z · Cited by 4
Metadata
- Authors
- Martineau, A. R., Newton, S. M., Wilkinson, K. A., Kampmann, B., Hall, B. M., Nawroly, N., Packe, G. E., Davidson, R. N., Griffiths, C. J., & Wilkinson, R. J.
- Affiliations
- Imperial College London (GB)
- University of Cape Town (ZA)
- Queen Mary University of London (GB)
- Newham University Hospital (GB)
- Northwick Park Hospital (GB)
- Venue
- Journal of Clinical Investigation
- Published
- 2007-07-02
- Volume
- 117
- Issue
- 7
- Pages
- 1988-1994
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1904316
- OpenAlex
- W2014262351
- Cited by
- 394
- References
- 37
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 13 · 2023: 16 · 2022: 15 · 2021: 23 · 2020: 15 · 2019: 31 · 2018: 27 · 2017: 29 · 2016: 19 · 2015: 21 · 2014: 26 · 2013: 29 · 2012: 20
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (077273, 072070, 066321, 064261)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- neutrophils, tuberculosis, Mycobacterium tuberculosis, Mycobacterium bovis BCG, antimicrobial peptides, human neutrophil peptides, cathelicidin LL-37, neutrophil gelatinase-associated lipocalin, innate immunity, TB contacts, neutrophil depletion, ethnic differences
- MeSH terms
- Female, Humans, Immunity, Innate, Leukocyte Count, Male, Mycobacterium bovis, Mycobacterium tuberculosis, Neutrophils, Tuberculosis, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review